Back to search
FDAFDA · Food and drugs·Recall number D-1094-2023

Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.

Published August 30, 2023 · Recall initiated: August 10, 2023

Summary

FDA records drug Class III recall D-1094-2023, published August 30, 2023 and initiated August 10, 2023. Recalling firm: Imprimis NJOF, LLC; Status: Terminated; Reported quantity: 2,683 bottles; Lot: Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Imprimis NJOF, LLC
Distributor
Nationwide in the US
Lot
Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05. recalled?

Yes. FDA published recall D-1094-2023 on August 30, 2023. Reported hazard: Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

What should I do if I have this product?

Voluntary: Firm initiated